Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data-Reference-Cited by-同舟云学术

Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data

Published:2019-08-12 Issue:9 Volume:15 Page:921-928
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Canonica Giorgio Walter¹^ORCID,Devillier Philippe²^ORCID,Casale Thomas³^ORCID,Demoly Pascal⁴^ORCID,Bos Catherine⁵^ORCID,Karagiannis Efstrathios⁵^ORCID,Passalacqua Giovanni⁶^ORCID,Wahn Ulrich⁷^ORCID,Mascarell Laurent⁵^ORCID

Affiliation:

1. Department of Internal Medicine, Humanitas University and Research Hospital ICH, Milan, Italy

2. UPRES EA220, Foch Hospital, University Versailles Saint-Quentin, University Paris-Saclay, Suresnes, France

3. Department of Internal Medicine, University of South Florida, Tampa, FL, USA

4. Division of Allergy, Department of Pulmonology, University Hospital of Montpellier, Montpellier and INSERM UMRS 1136, Equipe – EPAR – IPLESP, Sorbonne Université, Hôpital Arnaud de Villeneuve, Paris, France

5. Department of Internal Medicine, Stallergenes Greer, Antony, France

6. Allergy and Respiratory Diseases, IRCCS Policlinico San Martino, University of Genoa, Genoa, Italy

7. Department of Paediatric Pneumology and Immunology, Charité Medical University, Berlin, Germany

Funder

Stallergenes Greer

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2019.1649597

Reference42 articles.

1. Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience

2. Induction of Tolerance via the Sublingual Route: Mechanisms and Applications

3. Update on Immune Mechanisms Associated with Sublingual Immunotherapy: Practical Implications for the Clinician

4. ALK-Abelló/Merck. US prescribing information: Grastek® (Timothy grass pollen allergen extract) tablet for sublingual use; 2014 Available from: http://www.merck.com/product/usa/pi_circulars/g/grastek/grastek_pi.pdf

5. Stallergenes-Greer. US prescribing information: Oralair® (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky blue grass mixed pollens allergen extract) tablet for sublingual use; 2014 Available from: http://oralair.com/docs/ORALAIR%20Prescribing%20Information-Med%20Guide.pdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local nasal immunotherapy with birch pollen-galactomannan conjugate-containing ointment in mice and humans;Allergology International;2023-11

2. Targeting Lewis X oligosaccharide-modified liposomes encapsulated with house dust mite allergen Der f 2 to dendritic cells inhibits Th2 immune response;European Journal of Pharmaceutical Sciences;2023-11

3. Drug Delivery Systems;Kirk-Othmer Encyclopedia of Chemical Technology;2023-09-29

4. Update about Oralair® as a treatment for grass pollen allergic rhinitis;Human Vaccines & Immunotherapeutics;2022-06-15

5. Sublingual Boosting with a Novel Mucoadhesive Thermogelling Hydrogel Following Parenteral CAF01 Priming as a Strategy Against Chlamydia trachomatis;Advanced Healthcare Materials;2022-03-13